Effect of cytokines on the pathogenesis of mood disondens
细胞因子对情绪障碍发病机制的影响
基本信息
- 批准号:10470202
- 负责人:
- 金额:$ 2.94万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Two animal experiments were performed for investigating the effect of cytokines on the pathogenesis of mood disorder.(1) It is reported that cytokine, one of immune modulating factors, controls the stress response of hypothalamo-pituitary-adrenal axis (HPA axis) in the brain. There are few reports about the effects of cytokines on the vasopressin (VP), which is one of the HPA regulating peptide within the paraventricular nucleus (PVN). In this study, we examined the VP release by the microinjection of cytokines, interleukin-1 (IL-1β), tumor necrosis factor (TNF), interferon (IFN), in the PVN in the rat brain with the microdialysis technique. We also examined the effect of the interleukin-1 receptor antagonist (IL-1Ra) on the cytokine induced VP release. Male Wistar rats (8〜10 weeks old) were anesthetized with urethane (1.4g/kg, ip). Microdialysis probe was implanted into the PVN and samples were collected every 30 minutes. VP was measured by RIA.VP release was stimulated by the IL-1β and TNF, but VP not by IFN.These increases were prevented by the IL-1Ra pre-injection. These results indicate that I1-1β and TNF both regulate HPA axis through IL-1R.(2) Oligonucleotides targeting M5 muscarinic receptor mRNA were infused for 6 d into the ventral tegmental area of freely behaving rats trained to bar-press for lateral hypothalamic stimulation. M5 antisense oligonucleotide (oligo) infusions increased the frequency required for bar pressing by 48% over baseline levels, with the largest increases occurring after 4-6 d of infusion. Antisense oligo infusions decreased M5 receptors on the ipsilateral, but not the contralateral, side of the ventral tegmentum, as compared with a missense oligo. Therefore, M5 muscarinic receptors associated with mesolimbic dopamine neurons seem to be important in brain-stimulation reward.
本研究通过两个动物实验探讨了细胞因子在心境障碍发病机制中的作用。(1)细胞因子作为一种免疫调节因子,控制着脑内下丘脑-垂体-肾上腺轴(HPA轴)的应激反应。室旁核(PVN)内HPA调节肽之一的加压素(VP)在细胞因子作用下的研究较少。本研究应用微透析技术,观察了大鼠脑内PVN微量注射细胞因子白细胞介素-1(IL-1β)、肿瘤坏死因子(TNF)、干扰素(IFN)对VP释放的影响。我们还研究了白细胞介素-1受体拮抗剂(IL-1 Ra)对细胞因子诱导的VP释放的影响。雄性Wistar大鼠(8 ~ 10周龄)用乌拉坦(1.4g/kg,ip)麻醉。将微透析探针植入PVN中,每30分钟收集样品。结果表明,IL-1β和TNF可刺激VP释放,而IFN对VP释放无明显影响,IL-1 Ra可抑制VP释放。提示I1-1β和TNF均通过IL-1 R调节HPA轴。(2)靶向M5毒蕈碱受体mRNA的寡核苷酸注入到自由行为的大鼠的腹侧被盖区6天,训练大鼠进行下丘脑外侧刺激的压杆。M5反义寡核苷酸(oligo)输注使压杆所需的频率比基线水平增加了48%,最大增加发生在输注4-6天后。与错义寡核苷酸相比,反义寡核苷酸输注降低了同侧腹侧被盖上的M5受体,但对侧没有。因此,与中脑边缘多巴胺神经元相关的M5毒蕈碱受体似乎在脑刺激奖励中很重要。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeuchi J, Yeomans JS, Flynn D, Kanba S.: "Analysis of reward behavior by infusion of antisense oligodeoxynucleotide for the M5 muscarinic receptor"Ann Rep Pharmacopsychiat res Fund. 31. 76-82 (1999)
Takeuchi J、Yeomans JS、Flynn D、Kanba S.:“通过输注 M5 毒蕈碱受体反义寡脱氧核苷酸来分析奖励行为”Ann Rep Pharmacopsychiat res 基金。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yeomans JS,Takeuchi J,Baptista M,Flynn DD,Lepik K,Nobrega J,Fulton J,Ralph MR.: "Brain-Stimuration reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells"J Neurosci.. 20. 8861-8867 (2000)
Yeomans JS、Takeuchi J、Baptista M、Flynn DD、Lepik K、Nobrega J、Fulton J、Ralph MR.:“注入多巴胺细胞附近的 M5 毒蕈碱受体的反义寡核苷酸提高了脑刺激奖励阈值”J Neurosci..
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kanba S., Kubota M., Takeuchi J.: "New Challenges in neuropsychiatry."Singapore Med J. 41. 16-18 (2000)
Kanba S.、Kubota M.、Takeuchi J.:“神经精神病学的新挑战。”Singapore Med J. 41. 16-18 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kanba S.,Kubota M.,Takeuchi J.: "New Challenges in neuropsychiatry."Singapore Med J. 41. 16-18 (2000)
Kanba S.、Kubota M.、Takeuchi J.:“神经精神病学的新挑战。”Singapore Med J. 41. 16-18 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeuchi J,Yeomans JS,Flynn D,Kanba S.: "Analysis of reward behavior by infusion of antisense oligodeoxynucleotide for the M5 muscarinic receptor"Ann Rep Pharmacopsychiat res Fund. 31. 76-82 (1999)
Takeuchi J、Yeomans JS、Flynn D、Kanba S.:“通过输注 M5 毒蕈碱受体反义寡脱氧核苷酸来分析奖励行为”Ann Rep Pharmacopsychiat res 基金。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANBA Shigenobu其他文献
KANBA Shigenobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANBA Shigenobu', 18)}}的其他基金
Investigation of the brain and cell injury responsible for depression with immune-challenged animal model
用免疫缺陷动物模型研究导致抑郁症的大脑和细胞损伤
- 批准号:
22390226 - 财政年份:2010
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Disorder of reward circuit in bipolar disorders : integration of basic and clinical investigation
双相情感障碍中奖赏回路的紊乱:基础与临床研究的结合
- 批准号:
19390306 - 财政年份:2007
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on early environment-induced neuronal network which is involved in vulnerability to psychiatric disorders
早期环境诱发的神经元网络与精神疾病易感性的研究
- 批准号:
16390321 - 财政年份:2004
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Research on Environmental Influence on Neuroplasticity and Neurogenesis
环境对神经可塑性和神经发生影响的分子研究
- 批准号:
13470195 - 财政年份:2001
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A ROLE OF INTERLEUKIN-1 IN PATHOGENESIS OF MANIC-DEPRESSIVE-ILLNESS
白介素 1 在躁狂抑郁症发病机制中的作用
- 批准号:
08457252 - 财政年份:1996
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10801043 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
A Phase II Randomized Placebo Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Physical Frailty and Tumor Necrosis Factor-alpha and Associated Immune Markers in Older Cancer Survivors
表没食子儿茶素-3-没食子酸酯 (EGCG) 对老年癌症幸存者身体虚弱和肿瘤坏死因子-α 及相关免疫标志物的 II 期随机安慰剂对照试验
- 批准号:
10570438 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Investigating the Impact of Tumor Necrosis Factor Inhibitors on SARS-CoV-2 mRNA Vaccine-induced Immunity in Immunocompromised Patients with Immune-mediated Inflammatory Diseases
研究肿瘤坏死因子抑制剂对患有免疫介导炎症性疾病的免疫功能低下患者的 SARS-CoV-2 mRNA 疫苗诱导免疫的影响
- 批准号:
475681 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Studentship Programs
Investigating the role of tumor necrosis factor receptor associated factor 1 in animal models of inflammatory arthritis and lipopolysaccharide-induced septic shock
研究肿瘤坏死因子受体相关因子 1 在炎症性关节炎和脂多糖诱导的感染性休克动物模型中的作用
- 批准号:
490910 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Studentship Programs
Novel roles of C1q tumor necrosis factor-related proteins (CTRPs) in relaxin receptor biology
C1q 肿瘤坏死因子相关蛋白 (CTRP) 在松弛素受体生物学中的新作用
- 批准号:
RGPIN-2017-05485 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
Discovery Grants Program - Individual
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10296178 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10684910 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10887848 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
肿瘤坏死因子受体的控制和激活
- 批准号:
10338106 - 财政年份:2020
- 资助金额:
$ 2.94万 - 项目类别:
Activation of receptors of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) by heteromeric ligands of the TNF superfam,ily (TNFSF)
TNF 超家族 (TNFSF) 的异聚配体激活肿瘤坏死因子 (TNF) 受体超家族 (TNFRSF) 的受体
- 批准号:
436843377 - 财政年份:2020
- 资助金额:
$ 2.94万 - 项目类别:
Research Grants